The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile?

Detalles Bibliográficos
Autores principales: Quesada, Stanislas, Jacot, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Editorial Commentary | Biomarkers Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632578/
https://www.ncbi.nlm.nih.gov/pubmed/37970606
http://dx.doi.org/10.21037/atm-23-1608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632578/
https://www.ncbi.nlm.nih.gov/pubmed/37970606
http://dx.doi.org/10.21037/atm-23-1608

Ejemplares similares